You are here

Biblio

Search

Show only items where

Author

Type

Term

Year

Keyword

Export 48 results:

Filters: Author is Katz, Ronit and Keyword is Glomerular Filtration Rate [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Peralta CA, Ziv E, Katz R, Reiner A, Burchard EG, Fried L, Kwok P-Y, Psaty B, Shlipak M. African ancestry, socioeconomic status, and kidney function in elderly African Americans: a genetic admixture analysis. J Am Soc Nephrol. 2006 ;17(12):3491-6.

Rifkin DE, Katz R, Chonchol M, Fried LF, Cao J, de Boer IH, Siscovick DS, Shlipak MG, Sarnak MJ. Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant. 2010 ;25(5):1560-7.

Menon V, Katz R, Mukamal K, Kestenbaum B, de Boer IH, Siscovick DS, Sarnak MJ, Shlipak MG. Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease. Nephrol Dial Transplant. 2010 ;25(10):3301-7.

Odden MC, Tager IB, van der Laan MJ, Delaney JAC, Peralta CA, Katz R, Sarnak MJ, Psaty BM, Shlipak MG. Antihypertensive medication use and change in kidney function in elderly adults: a marginal structural model analysis. Int J Biostat. 2011 ;7(1):Article 34.

Seshasai RKurnik, Katz R, de Boer IH, Siscovick D, Shlipak MG, Rifkin DE, Sarnak MJ. Apolipoprotein E and kidney function in older adults. Clin Nephrol. 2012 ;78(3):174-80.

Rifkin DE, Katz R, Fried LF, Kestenbaum B, Jenny NSwords, Newman AB, Siscovick DS, Shlipak MG, Sarnak MJ. Association between baseline kidney function and change in CRP: an analysis of the cardiovascular health study. Nephron Clin Pract. 2010 ;115(2):c114-21.

O'Seaghdha CM, Tin A, Yang Q, Katz R, Liu Y, Harris T, Astor B, Coresh J, Fox CS, Kao LWH, et al. Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality. Am J Kidney Dis. 2014 ;63(1):16-22.

Ix JH, Katz R, de Boer IH, Kestenbaum BR, Allison MA, Siscovick DS, Newman AB, Sarnak MJ, Shlipak MG, Criqui MH. Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). J Am Coll Cardiol. 2009 ;54(13):1176-84.

Asselbergs FW, Mozaffarian D, Katz R, Kestenbaum B, Fried LF, Gottdiener JS, Shlipak MG, Siscovick DS. Association of renal function with cardiac calcifications in older adults: the cardiovascular health study. Nephrol Dial Transplant. 2009 ;24(3):834-40.

B

Rifkin DE, Katz R, Chonchol M, Shlipak MG, Sarnak MJ, Fried LF, Newman AB, Siscovick DS, Peralta CA. Blood pressure components and decline in kidney function in community-living older adults: the Cardiovascular Health Study. Am J Hypertens. 2013 ;26(8):1037-44.

C

Shastri S, Tighiouart H, Katz R, Rifkin DE, Fried LF, Shlipak MG, Newman AB, Sarnak MJ. Chronic kidney disease in octogenarians. Clin J Am Soc Nephrol. 2011 ;6(6):1410-7.

Shlipak MG, Katz R, Kestenbaum B, Fried LF, Siscovick D, Sarnak MJ. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis. 2009 ;204(1):298-303.

de Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K, Rifkin DE, Sarnak MJ, Shlipak MG, Siscovick DS. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care. 2009 ;32(10):1833-8.

Sarnak MJ, Katz R, Fried LF, Siscovick D, Kestenbaum B, Seliger S, Rifkin D, Tracy R, Newman AB, Shlipak MG. Cystatin C and aging success. Arch Intern Med. 2008 ;168(2):147-53.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006 ;145(4):237-46.

Deo R, Sotoodehnia N, Katz R, Sarnak MJ, Fried LF, Chonchol M, Kestenbaum B, Psaty BM, Siscovick DS, Shlipak MG. Cystatin C and sudden cardiac death risk in the elderly. Circ Cardiovasc Qual Outcomes. 2010 ;3(2):159-64.

Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005 ;352(20):2049-60.

Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NSwords, Psaty BM, Newman AB, Siscovick D, Shlipak MG. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005 ;142(7):497-505.

Peralta CA, Katz R, Sarnak MJ, Ix J, Fried LF, de Boer I, Palmas W, Siscovick D, Levey AS, Shlipak MG. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol. 2011 ;22(1):147-55.

Shlipak MG, Matsushita K, Arnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013 ;369(10):932-43.

Shlipak MG, Katz R, Cushman M, Sarnak MJ, Stehman-Breen C, Psaty BM, Siscovick D, Tracy RP, Newman A, Fried L. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med. 2005 ;118(12):1416.

Shlipak MG, Katz R, Fried LF, Jenny NSwords, Stehman-Breen CO, Newman AB, Siscovick D, Psaty BM, Sarnak MJ. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol. 2005 ;45(2):268-71.

D

Bansal N, Katz R, de Boer IH, Peralta CA, Fried LF, Siscovick DS, Rifkin DE, Hirsch C, Cummings SR, Harris TB, et al. Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. Clin J Am Soc Nephrol. 2015 ;10(3):363-71.

Beasley JM, Katz R, Shlipak M, Rifkin DE, Siscovick D, Kaplan R. Dietary protein intake and change in estimated GFR in the Cardiovascular Health Study. Nutrition. 2014 ;30(7-8):794-9.

F

Mathew JS, Sachs MC, Katz R, Patton KK, Heckbert SR, Hoofnagle AN, Alonso A, Chonchol M, Deo R, Ix JH, et al. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS). Circulation. 2014 ;130(4):298-307.

Pages